{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T15:28:14Z","timestamp":1778167694622,"version":"3.51.4"},"reference-count":42,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Ther Adv Neurol Disord"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Although migraine is the second most prevalent form of headache, its preventive treatment has some contraindications and complications. It has been postulated that lacosamide reacts with collapsin response mediator protein 2 and prevents its phosphorylation, inhibiting calcitonin gene-related peptide release in the trigeminal system, which might have a role in migraine management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>Our study aimed mainly to evaluate the efficacy and safety of lacosamide as an alternative medication to topiramate for the prevention of migraine, especially in patients who had contraindications to topiramate and other approved antiseizure medications used for migraine prevention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>Our study included two parallel groups: the lacosamide and the topiramate groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We recruited episodic migraine patients between the ages of 18 and 65; the lacosamide group received lacosamide 50\u2009mg once daily for 1\u2009week, then twice daily from the 8th day till the 90th day); while the topiramate group received topiramate 50\u2009mg once daily for 1\u2009week, then 50\u2009mg twice daily from the 8th day till the 90th day.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      There was not a statistically significant difference between the lacosamide and topiramate in the absolute change in monthly migraine days (MMD) at 90\u2009days with\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      -value 0.34, there was no significant difference between lacosamide and topiramate groups regarding the percentage of patients with \u2a7e50% reduction in the baseline migraine days frequency in the last 4\u2009weeks of the treatment period with a\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      -value 0.11. In total, 14.0 (4.7%) patients in the lacosamide group and 24.0 (8.0%) in the topiramate group stopped treatment prematurely due to intolerance to drug-related adverse effects, hazard ratio 2.83, 95% confidence interval (1.34\u20134.72),\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      -value 0.03.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>In episodic migraine patients, the regular use of lacosamide 50\u2009mg Bid for 3\u2009months yielded reductions in the MMD, migraine days that required acute medications, and Headache Impact Test-6 score comparable to those achieved using topiramate 50\u2009mg Bid. Lacosamide was more tolerable than topiramate in episodic migraine patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration:<\/jats:title>\n                    <jats:p>\n                      Prospectively registered on clinicaltrials.gov, NCT06243692\u2014January 29, 2024;\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/study\/NCT06243692\">https:\/\/clinicaltrials.gov\/study\/NCT06243692<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/17562864251396529","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T08:20:33Z","timestamp":1765268433000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Lacosamide versus topiramate in episodic migraine: a randomized controlled double-blinded trial"],"prefix":"10.1177","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0337-349X","authenticated-orcid":false,"given":"Mohamed G.","family":"Zeinhom","sequence":"first","affiliation":[{"name":"Neurology Department, Faculty of Medicine, Kafr EL Sheikh University, Elgeish Street, Kafr El Sheikh 33511, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Fouad Elsayed","family":"Khalil","sequence":"additional","affiliation":[{"name":"Neurology Department, NMC Royal Hospital\u2014Mohammed Bin Zayed, Abu Dhabi, United Arab Emirates"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Almoataz","sequence":"additional","affiliation":[{"name":"Neurology Department, Saudi German Hospital, Sharjah, United Arab Emirates"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarek Youssif Omar","family":"Youssif","sequence":"additional","affiliation":[{"name":"Neurology Department, Burjeel Medical City, Abu Dhabi, United Arab Emirates"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed Mohamed Ali","family":"Daabis","sequence":"additional","affiliation":[{"name":"Neurology Department, Burjeel Royal Hospital, Al Ain, United Arab Emirates"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossam Mohamed","family":"Refat","sequence":"additional","affiliation":[{"name":"Neurology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed Ahmed Mohamed Kamal","family":"Ebied","sequence":"additional","affiliation":[{"name":"Neurology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shady S.","family":"Georgy","sequence":"additional","affiliation":[{"name":"Neurology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed Zaki Omar","family":"Akl","sequence":"additional","affiliation":[{"name":"Neurology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8501-3007","authenticated-orcid":false,"given":"Mohamed","family":"Ismaiel","sequence":"additional","affiliation":[{"name":"Neurology Department, Al-Sahel Teaching Hospital, Cairo, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salah Ibrahim","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Neurology Department, Faculty of Medicine, Al-Azhar University, Assiut, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hesham Farouk","family":"Eissa","sequence":"additional","affiliation":[{"name":"Neurology Department, Sheikh Sultan bin Zayed Hospital, Al Batayeh, United Arab Emirates"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asmaa Ibrahem Desouky Mostafa","family":"Ibrahem","sequence":"additional","affiliation":[{"name":"Neurology Department, Amina Hospital, Ajman, United Arab Emirates"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asmaa Mohammed","family":"Hassan","sequence":"additional","affiliation":[{"name":"Neurology Department, Medeor Hospital, Abu Dhabi, United Arab Emirates"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Elshafei","sequence":"additional","affiliation":[{"name":"Neurology Department, Zulekha Hospital, Dubai, United Arab Emirates"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir Ahmed Elsaeed","family":"Egila","sequence":"additional","affiliation":[{"name":"Neurology Department, Security Forces Hospital, Riyadh, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherihan Rezk","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Neurology Department, Faculty of Medicine, Kafr El Sheikh University, Kafr El Sheikh, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13760-022-02015-x"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-025-08373-7"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30499-X"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2011.11.021"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/head.13407"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1705848"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1177\/0333102420905132"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32534-0"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.4853"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2018.1212"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-022-01431-x"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2025.111156"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.3109\/00207454.2011.626908"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2009.01.322"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2006.10.008"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.694381"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182a6cb72"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1177\/0333102413485658"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13760-024-02499-9"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2013.10391"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1177\/03331024211047454"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-025-02047-7"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1177\/03331024211053571"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1177\/0333102421989601"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-024-01727-0"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1177\/0333102411417901"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1177\/0333102419883355"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/head.13459"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-020-01111-8"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-023-11880-2"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2009.01544.x"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70251-0"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ajp.0000210957.39621.b2"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-019-3695-7"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/ejp.2165"},{"key":"e_1_3_5_37_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.712717"},{"key":"e_1_3_5_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2020.107663"},{"key":"e_1_3_5_39_2","doi-asserted-by":"publisher","DOI":"10.1177\/1941874412446200"},{"key":"e_1_3_5_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2013.11.016"},{"key":"e_1_3_5_41_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-013-0123-5"},{"key":"e_1_3_5_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2021.106710"},{"key":"e_1_3_5_43_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.891368"}],"container-title":["Therapeutic Advances in Neurological Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17562864251396529","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/17562864251396529","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17562864251396529","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T17:32:31Z","timestamp":1769362351000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/17562864251396529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":42,"alternative-id":["10.1177\/17562864251396529"],"URL":"https:\/\/doi.org\/10.1177\/17562864251396529","relation":{},"ISSN":["1756-2864","1756-2864"],"issn-type":[{"value":"1756-2864","type":"print"},{"value":"1756-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11]]},"article-number":"17562864251396529"}}